Lazard Asset Management LLC Kymera Therapeutics, Inc. Transaction History

Lazard Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$29.85 - $39.42 $85,251 - $112,583	2,856 New	2,856 $85,000
Q1 2022 May 13, 2022	SELL	$35.3 - $64.68 $43,701 - $80,073	-1,238 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$49.91 - $65.56 $61,788 - $81,163	1,238 New	1,238 $78,000
Q3 2021 Nov 15, 2021	SELL	$47.8 - $66.66 $72,273 - $100,789	-1,512 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$31.08 - $51.95 $46,992 - $78,548	1,512 New	1,512 $73,000

184

64.4M

50.6K

81.7K

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.22B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Lazard Asset Management LLC with notifications on news.